SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+5.52%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$298M
AUM Growth
+$298M
(+8.7%)
Cap. Flow
+$1.75M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
62
New
14
Increased
14
Reduced
17
Closed
13
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$13.5M |
| 2 |
Eli Lilly
LLY
|
$9.18M |
| 3 |
Bristol-Myers Squibb
BMY
|
$5.68M |
| 4 |
Merck
MRK
|
$4.67M |
| 5 |
Illumina
ILMN
|
$3.79M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$7.99M |
| 2 |
Intuitive Surgical
ISRG
|
$7.39M |
| 3 |
Becton Dickinson
BDX
|
$7.3M |
| 4 |
Agilent Technologies
A
|
$6.65M |
| 5 |
Fresenius Medical Care
FMS
|
$5.35M |
Sector Composition
| 1 | Healthcare | 94.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $13.5M | 2.64% | +100,000 | New | +$13.5M |
|
2
Humana
HUM
$36.5B
| $11.1M | 2.16% | 25,000 +5,000 | +25% | +$2.21M |
|
3
UnitedHealth
UNH
$281B
| $11M | 2.15% | 27,500 +7,500 | +38% | +$3M |
|
4
Universal Health Services
UHS
$11.6B
| $11M | 2.14% | 75,000 +10,000 | +15% | +$1.46M |
|
5
Centene
CNC
$14.3B
| $10.2M | 1.99% | 140,000 +15,000 | +12% | +$1.09M |
|
6
Molina Healthcare
MOH
$9.8B
| $10.1M | 1.98% | 40,000 +5,000 | +14% | +$1.27M |
|
7
Tenet Healthcare
THC
$16.3B
| $10M | 1.96% | 150,000 -50,000 | -25% | -$3.35M |
|
8
Medtronic
MDT
$119B
| $9.93M | 1.94% | 80,000 | – | – |
|
9
Zimmer Biomet
ZBH
$21B
| $9.65M | 1.88% | 60,000 -5,000 | -8% | -$804K |
|
10
Charles River Laboratories
CRL
$8.04B
| $9.25M | 1.81% | 25,000 +2,500 | +11% | +$925K |
|
|
11
Eli Lilly
LLY
$657B
| $9.18M | 1.79% | +40,000 | New | +$9.18M |
|
12
Johnson & Johnson
JNJ
$427B
| $9.06M | 1.77% | 55,000 +20,000 | +57% | +$3.29M |
|
13
Avantor
AVTR
$9.18B
| $8.88M | 1.73% | 250,000 +50,000 | +25% | +$1.78M |
|
14
IQVIA
IQV
$32.4B
| $8.48M | 1.66% | 35,000 -10,000 | -22% | -$2.42M |
|
15
Boston Scientific
BSX
$156B
| $8.12M | 1.59% | 190,000 -35,000 | -16% | -$1.5M |
|
16
Danaher
DHR
$147B
| $8.05M | 1.57% | 30,000 -7,500 | -20% | -$2.01M |
|
17
McKesson
MCK
$85.4B
| $7.65M | 1.49% | 40,000 +10,000 | +33% | +$1.91M |
|
|
CTLT
18
DELISTED
CATALENT, INC.
CTLT
| $7.57M | 1.48% | 70,000 -2,500 | -3% | -$270K |
|
19
Bruker
BRKR
$5.16B
| $7.22M | 1.41% | 95,000 +15,000 | +19% | +$1.14M |
|
20
Biogen
BIIB
$19.4B
| $6.93M | 1.35% | 20,000 +7,500 | +60% | +$2.6M |
|
21
Waters Corp
WAT
$18B
| $6.91M | 1.35% | 20,000 -1,500 | -7% | -$518K |
|
22
Labcorp
LH
$23.1B
| $6.9M | 1.35% | 25,000 | – | – |
|
23
Stryker
SYK
$150B
| $6.49M | 1.27% | 25,000 -10,000 | -29% | -$2.6M |
|
24
HCA Healthcare
HCA
$94.5B
| $6.2M | 1.21% | 30,000 -10,000 | -25% | -$2.07M |
|
25
Abbott
ABT
$231B
| $5.8M | 1.13% | 50,000 -15,000 | -23% | -$1.74M |
|